SWOG clinical trial number
SWOG-8726
Evaluation of Amonafide in Refractory Multiple Myeloma
Closed
Phase
Accrual
57%
Published
Abbreviated Title
Evaluation of Amonafide in Refractory Multiple Myeloma
Activated
04/01/1988
Closed
11/01/1989
Publication Information Expand/Collapse
1991
Evaluation of amonafide in refractory and relapsing multiple myeloma: A Southwest Oncology Group study.